Among overweight women, whether their waist circumference crosses the metabolic risk threshold of 88cm predicts their inflammatory status better than their BMI category does. Those with high-risk waist circumference have a high-CRP prevalence of 27.1%. Those with low-risk waist circumference: 4.4%. Same BMI band. A sixfold difference in inflammatory risk.

That gap is the core problem with relying on body weight alone.

The Hidden Risk Inside "Normal" BMI

BMI is a blunt instrument. It captures total mass, not distribution. And for a meaningful share of adults who register as clinically normal, that distinction carries real consequences.

Among normal-BMI adults, 9.3% are women whose waist circumference exceeds the 88cm metabolic risk threshold. That group has a weighted mean hsCRP of 1.67 mg/L, compared to 1.43 mg/L for normal-BMI women with low-risk waist circumference. The absolute difference looks modest, but the prevalence of high-risk CRP (above 3 mg/L) tells a sharper story: 15.2% for high-waist normal-BMI women versus 8.1% for their low-waist counterparts. Nearly double the rate of clinically elevated inflammation, in people a standard clinical intake would classify as healthy weight.

The pattern holds for men. Normal-BMI men with high-risk waist circumference show a weighted mean hsCRP of 3.22 mg/L and a high-CRP prevalence of 18%, compared to 2.01 mg/L and 11.3% for normal-BMI men with low-risk waist circumference. These are people who would not trigger a weight-based intervention in most clinical settings. Their inflammatory profiles suggest they should.

Where the Risk Compounds

The most striking numbers come from the obese category, and they set a useful ceiling for understanding the gradient. Obese women with high-risk waist circumference have a weighted mean hsCRP of 6.83 mg/L and a high-CRP prevalence of 56.3%. More than half of that group carries systemic inflammation at a level associated with elevated cardiovascular risk. For context, the clinical threshold for high CRP is 3 mg/L. Their average is more than double that.

But the more policy-relevant finding may be in the middle of the distribution, among adults who are overweight or normal-weight but carry abdominal fat above the risk threshold. Among adults aged 40 to 69 with high-risk waist circumference and BMI under 30, 35.9% have hypertension, 13.4% have diabetes, and 46.9% have high cholesterol. Those are not the numbers of a low-risk population. They are close to the figures for obese adults with high-risk waist circumference, who show 50.0% hypertension, 21.1% diabetes, and 49.9% high cholesterol.

The cardiometabolic burden in the non-obese, high-waist group is not dramatically lower than in the obese group. The difference is that the obese group is far more likely to be flagged, monitored, and treated.

The Measurement That Gets Skipped

The table above makes the waist-circumference gradient visible in a way BMI alone cannot. Overweight women with low-risk waist circumference have a high-CRP prevalence of 4.4%, lower than normal-BMI women with high-risk waist circumference at 15.2%. BMI rank and inflammatory risk rank are not the same list.

Waist circumference takes about ten seconds to measure. Among adults aged 40 to 69 with high-risk waist circumference but BMI under 30, 46.9% already have high cholesterol. What proportion of those individuals are currently undiagnosed or untreated, precisely because their BMI kept them off the clinical radar?